Keywords: HCC; CI; confidence interval; HCC; hepatocellular carcinoma; HR; hazard ratio; INR; international normalization ratio; mRECIST; modified response evaluation criteria in solid tumor;
مقالات ISI HCC (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: HCC; Inflammatory liver lesion; HCC; Contrast-enhanced ultrasound; Differential diagnosis;
Keywords: HCC; HCC; hepatocellular carcinoma; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; NIS; Nationwide Inpatient Sample; OR; odds ratio; SEER; Surveillance, Epidemiology, and End Results Program; TACE; transarterial chem
Keywords: HCC; AFP; α-fetoprotein; DSC; DICE similarity coefficient; HCC; hepatocellular carcinoma; LTP; local tumor progression; RF; radiofrequency; ROI; region of interest; 3D; three-dimensional; THRIVE; T1 high resolution isotropic volume excitation;
Keywords: HCC; 2-AB; 2-aminobanzamide; AFP; α-fetoprotein; AGP; α1-acid glycoprotein; BMI; body mass index; CDG; congenital disorders of glycosylation; CEA; carcinoembryonic antigen; CRP; C-reactive protein; CVD; cardiovascular disease; DAS28; Disease Activity Score b
Keywords: HCC; ART score; TACE; HCC; Chinese patients;
Keywords: HCC; ADSC; Adipose stromal cells; Akt; protein kinase B; BM-MSC; bone marrow mesenchymal stem cells; CAF; cancer associated fibroblast; CRC; colorectal cancer; CSC; cancer stem cell; HCC; hepatocellular carcinoma; IGF; insulin-like-growth factor; IL-1; interle
Keywords: HCC; CI; confidence interval; CR; complete response; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; IQR; interquartile range; LEM; Lipiodol and ethanol mixture; OS; overall survival; PFS; progression-free survival; TEA; transarterial ethanol ablation;
Keywords: HCC; PBT; Perioperative blood transfusion; HCC; Hepatocellular carcinoma; OS; Overall survival; DFS; Disease-free survival; HR; Hazard ratio; 95% CI; 95 percent confidence interval; ECOG; Eastern Cooperative Oncology Group; AFP; Alpha-fetoprotein; US; Ultrason
Keywords: HCC; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Liver fibrosis; Noninvasive diagnosis; Children; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis;; HCC; hepatocellular carcinoma; ALT; alanine aminotransferase; NH
Keywords: HCC; ACC; acetyl coenzyme A carboxylase; BMI; body mass index; DM; diabetes mellitus; FAS; fatty acid synthase; β-HAD; β-hydroxyacyl-CoA dehydrogenase; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; IHF; intrahepatic fat; MDA;
Keywords: HCC; AST; aspartate aminotransferase; BSA; body surface area; CI; confidence interval; CP; Child-Pugh; HCC; hepatocellular carcinoma; HR; hazard ratio; OS; overall survival; PVT; portal vein thrombosis; TTP; time to progression; TTT; time to toxicity; 90Y; ytt
Keywords: HCC; β-hCG; β-human chorionic antigen; AFP; α-fetoprotein; AFP-L3; core fucosylated α-fetoprotein; ALC; heavy alcohol consumption; CA; carbohydrate antigen; CEA; carcinoembryonic antigen; EGF; endothelial growth factor; EGFR; endothelial growth factor rece
Keywords: HCC; DW; diffusion-weighted; MRI; magnetic resonance imaging; CE; contrast-enhanced; US; ultrasound; CT; computed tomography; PET; positron emission tomography; HCC; hepatocellular carcinoma; MFC; mass-forming cholangiocarcinoma; OATP; organic anionic transpor
Keywords: HCC; ALI; acute lung injury; FFP; fresh frozen plasma; FLR; future liver remnant; HCC; hepatocellular carcinoma; INR; international normalized ratio; ISGLS; International Study Group of Liver Surgery; OLT; orthotopic liver transplantation; POHF; postoperative
Keywords: HCC; PLF; postresectional liver failure; INR; international normalized ratio; RLV; remnant liver volume; CALI; chemotherapy-associated liver injury; CRLM; colorectal cancer liver metastasis; HCC; hepatocellular carcinoma; CCA; cholangiocarcinoma; SOS; sinusoid
Keywords: HCC; VEGF; Inflammation; Cirrhosis; Portal Hypertension; CCl4; carbon tetrachloride; EHE; epithelioid hemangioendothelioma; HA; hyaluronan; HBx Ag; hepatitis B x antigen; HCC; hepatocellular carcinoma; IFN; interferon; IL; interleukin; LSEC; liver sinusoidal e
Keywords: HCC; Cognition; Hair cortisol; HCC; Hypothalamus-pituitary-adrenal axis; HPA; Cortisol;
Keywords: HCC; Waitlist Outcomes; Post-Transplantation Outcomes; Transplant-Related Survival Benefit; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; MELD; Model for End-Stage Liver Disease; NASH; nonalcoholic steatohepatitis; UNOS; United Network for Organ Shari
Keywords: HCC; Fatty Liver Disease; Latinos; Epidemiology; GWAS; genome-wide association study; HCC; hepatocellular carcinoma; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; PNPLA3; patatin-like phospholipase domain containing 3; T2DM; type
Keywords: HCC; Dysplasia; Surveillance; Thiopurines; Bile Duct Tumor; Immunosuppressant; AIH; autoimmune hepatitis; CCA; cholangiocarcinoma; HCC; hepatocellular carcinoma; IBD; inflammatory bowel disease; PSC; primary sclerosing cholangitis; Q; quartile; UDCA; ursodeoxy
Keywords: HCC; ALT; alanine transaminase; AST; aspartate transaminase; BMI; body mass index; CBT; cognitive behavioral therapy; HOMA-IR; homeostasis model assessment of insulin resistance; HCC; hepatocellular carcinoma; IHTG; intrahepatic triglycerides; MR-S; magnetic r
Keywords: HCC; 4-HNE; 4-hydroxynonenal; ALT; Alanine aminotransferase; BSA; Bovine serum albumin; DTNB; 5,5-dithiobis-2-nitrobenzoic acid; DTT; dithiothreitol; G6P; Glucose 6-phosphate; G6PDH; Glucose 6-phosphate dehydrogenase; GSH; Glutathione; HCC; hepatocellular carc
Keywords: HCC; Liver cancer; Progenitor cells; Thalidomide; Analogues; Lenalidomide; Sorafenib; Apoptosis; Mitosis; LPCs; liver progenitor cells; HCC; hepatocellular carcinoma; FDA; Federal Drug Administration; SAR; structure activity relationship; BMOL; bipotential mou
Keywords: HCC; Liver Cancer; Fatty Liver; NASH; Steatosis; AFP; alpha-fetoprotein; APRI; aspartate aminotransferase to platelet ratio; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; EMR; electronic medical record; HBV; hepatitis B virus; HCC; hepatocellul
Keywords: HCC; HCC; hepatocellular carcinoma; AASLD/BCLC; American Association for the Study of the Liver Disease/Barcelona Clinic for Liver Cancer; PVTT; portal vein tumor thrombosis; MST; median survival time; LR; liver resection; CI; confidence interval; TACE; transc
Keywords: HCC; miR or miRNA; microRNA; AD; Alzheimer's disease; MCI; mild cognitive impairment; CSF; cerebral spinal fluid; ECF; extracellular fluid; AUC; area under curve; ROC; receiver operating characteristic; mRNA; messenger RNA; RISC; RNA-induced silencing complex;
Keywords: HCC; BIR; baculovirus inhibitor of apoptosis protein repeat; Bcl-2; B-cell lymphoma 2; CASP3; caspase-3; CASP9; caspase-9; CYC2; cytochrome c; DMEM; Dulbecco's Modified Eagle Medium; FBS; fetal bovine serum; HCC; human hepatocellular carcinoma; HPRT1; hypoxant
Keywords: HCC; AF; atrial fibrillation; CVD; cardiovascular disease; FHBL; familial hypobetalipoproteinemia; FRS; Framingham risk score; GGT; gamma-glutamyltransferase; GWAS; genome wide association study; HCC; hepatocellular carcinoma; MetS; metabolic syndrome; NAFLD;
Keywords: HCC; HCC; hepatocellular carcinoma; DDS; drug delivery system; ECM; extracellular matrix; MVD; microvessel density; EPR; enhanced permeability and retention; ASGP-R; asialoglycoprotein receptor; GPC3; glypican 3; HS chain; heparin sulfate chain; GA; glycyrrhet
Keywords: HCC; HCC; hepatocellular carcinoma; DHA; docosahexaenoic acid; PUFA; polyunsaturated fatty acid; LPO; lipid peroxidation; ROS; reactive oxygen species; COX; cyclooxygenase; LOX; lipoxygenase; LDL; low density lipoprotein; LDL-DHA; low density lipoprotein recon
Keywords: HCC; VP; variegate porphyria; AIP; acute intermittent porphyria; HCP; hereditary coproporphyria; AHP; acute hepatic porphyrias; PPOX; protoporphyrinogen oxidase; HMBS; hydroxymethylbilane synthase; HCC; hepatocellular carcinoma; MRI; magnetic resonance imaging
Keywords: HCC; HCC; hepatocellular carcinoma; RF; radiofrequency;
Keywords: HCC; SBRT; stereotactic body radiation therapy; HCC; hepatocellular carcinoma; RECIST; response evaluation criteria in solid tumors; CTCAE; common terminology criteria for adverse events; LC; local control; OS; overall survival; PFS; progression-free survival;
Keywords: HCC; Therapy; Screening; Hepatitis C; Hepatitis B; Cirrhosis; AFP; α-fetoprotein; HCC; hepatocellular carcinoma; PCP; primary care provider; RCT; randomized controlled trial; US; ultrasound;
Keywords: HCC; Transarterial therapy; follow-up; hepatic malignancy; survey; IO; Interventional Oncology; IR; Interventional Radiology; LRT; locoregional therapy; SIR; Society of Interventional Radiology; CT; computed tomography; TACE; transarterial chemoembolization; c
Keywords: HCC; HCC; hepatocellular carcinoma; GEO; Gene Expression Omnibus; DEGs; differentially expressed genes; RMA; Robust Multi-Array; FDR; false discovery rate; MRSA; methicillin-resistant S. aureus.; Hepatocellular carcinoma; Transcriptome profiling; Differentiall
Keywords: HCC; HCC; hepatocellular carcinoma; RNAi; RNA interference; GSN; Gelsolin; IHC; immunohistochemistry; qRT-PCR; quantitative real-time reverse-transcription; GSN; HCC; Cell proliferation; Cell invasion;
Keywords: HCC; ALPPS; associating liver partition and portal vein ligation for staged hepatectomy; ALTPS; associating liver tourniquet and portal ligation for staged hepatectomy; FLR; future liver remnant; HCC; hepatocellular carcinoma; PHLF; posthepatectomy liver failu
Keywords: HCC; Ablation; Chemoembolization; Combined therapy; HCC; RFA;
Keywords: HCC; HCC; hepatocellular carcinoma; TACE; transarterial chemoembolization; OS; overall survival; EASL; European Association for the Study of the Liver; mRECIST; modified Response Evaluation Criteria in Solid Tumors; CT; computed tomography; CR; complete respon
Keywords: HCC; HCC; hepatocellular carcinoma; RF; radiofrequency;
Keywords: HCC; GM; geometic mean; HCC; hepatocellular carcinoma; HV; hepatic vein; LSF; lung shunt fraction; MAA; macroaggregated albumin; OR; odds ratio; PV; portal vein; 99mTc; technetium-99m; 90Y; yttrium-90;
Keywords: HCC; Botulinum neurotoxin; Botulism; Synaptotagmin; Synaptic vesicle glycoprotein 2; Protein complex; Host-pathogen recognition; botulinum neurotoxin; BoNT; light chain; LC; heavy chain; HC; N-terminal domain of HC; HN; C-terminal domain of HC; HC; N-terminal
Keywords: HCC; FL-MCs; fetal liver mesothelial cells; P-MCs; peritoneal mesothelial cells; HCC; hepatocellular carcinoma; PHx; partial hepatectomy; PPHx; practical partial hepatectomy; AST; aspartate aminotransferase; ALT; alanine aminotransferase; POD; postoperative da
Keywords: HCC; ERK; extracellular signal-regulated kinase; EGFR; epidermal growth factor receptor; ELISA; enzyme-linked immunosorbent assay; FFPE; formalin-fixed paraffin-embedded; FISH; fluorescence in situ hybridization; FNA; fine-needle aspiration; F/RPPA; forward/re
Keywords: HCC; Outcome; Liver Cancer; Therapy; Hepatic; AUROC; BCLC; Barcelona Clinic Liver Cancer; CI; confidence interval; HAP; hepatic arterial embolization prognostic; HCC; hepatocellular carcinoma; HR; hazard ratio; mHAP; modified hepatic arterial embolization prog
Keywords: HCC; Fibrinogen like protein-1; Hepatocellular carcinoma; Diethyl nitrosamine; Hepatoprotecatant; Mitogen; HCC; hepatocellular cancer; DEN; diethyl nitrosamine; Pb; phenobarbital; Fgl1; fibrinogen like protein-1; UHRF1; ubiquitin-like with PHD and ring finger
Keywords: HCC; BMI; body mass index; DEN; diethylnitrosamine; HCA; hepatocellular adenoma; HCC; hepatocellular carcinoma; NC; normal chow; WD-L; Western diet-lard; WD-C; Western diet-coconut oil; FD; fructose diet; KD; ketogenic diet; HOMA-IR; Homeostatic Model Assessme
Keywords: HCC; HCC; hepatocellular carcinoma; BCLB; Barcelona Clinic Liver Cancer; LRT; loco-regional therapy; BCT; best supportive care; MS; median survival; PST; performance status; ECOG; Easter Cooperative Oncology Group; CRPH; clinically relevant portal hypertension